Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy Development
A completed clinical trial study investigates how stool microbiota in two diverse Asian cohorts may influence the development of allergic di…
-
FDA approval · 2014-01-06FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochlori…
-
FDA approval · 2014-01-03FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin-D 24 Hour, a loratadine/pseudoephedrine sulfate combination from Bayer HealthCare L…
-
FDA approval · 2013-12-30FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy
This clinical trial update reports symptom control outcomes for allergic rhinitis patients three years after starting immunotherapy, with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Intranasal Steroids and Oxymetazoline in Allergic Rhinitis [Phase 4]
A Phase 4 clinical trial evaluating intranasal steroids in combination with oxymetazoline for allergic rhinitis has completed and results ha…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis [Phase 3]
A Phase 3 trial comparing levocetirizine with loratadine for perennial allergic rhinitis has completed, assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of levocetirizine in subjects with perennial allergic rhinitis due to house dust…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis [Phase 3]
Phase 3 randomized trial comparing levocetirizine with loratadine for the treatment of seasonal allergic rhinitis to evaluate efficacy and s…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis) [Phase 4]
Phase 4 LEADER trial evaluating levocetirizine and desloratadine for allergic rhinitis has completed, sponsored by UCB Pharma.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Study of Dust Mite Inhalation in Humans [Phase 1]
Phase 1 clinical trial update on inhalation of dust mite allergen in humans, evaluating safety in individuals with mild asthma or allergic c…
-
FDA approval · 2013-12-09FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for CHILDRENS ALLEGRA ALLERGY (fexofenadine hydrochloride) from Chattem, Inc., indicating an approve…
-
FDA approval · 2013-12-07FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Nasacort Allergy 24HR (triamcinolone acetonide) submitted by Chattem, Inc.
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Glasgow Asthma and Allergy Study
The Glasgow Asthma and Allergy Study clinical trial has completed. It investigated asthma and allergic rhinitis.
-
FDA label_change · 2013-11-29FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for levocetirizine dihydrochloride submitted by Glenmark Pharmaceuticals Inc., USA. This action …
-
FDA approval · 2013-11-29FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA granted a supplemental approval for Levocetirizine dihydrochloride by Teva Pharmaceuticals USA, Inc. (generic) under an ANDA supplement.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma [Phase 2]
Phase 2 dose-finding study evaluating four doses of Depigoid Phleum in patients with allergic rhinitis/rhinoconjunctivitis, with or without …
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation [Phase 3]
A Phase 3 trial evaluating a high-dose sublingual grass pollen preparation shows efficacy and safety data in allergic rhinitis and allergic …
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Efficacy and Safety From a Recombinant Folding Variant of Bet v 1 [Phase 3]
Phase 3 trial update of a recombinant Bet v 1 allergen assessing efficacy and safety in birch pollen allergy. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens [Phase 2]
A Phase 2 dose-response study of a recombinant Phleum grass pollen allergen cocktail (rPhleum) in Type I allergy has completed.
-
FDA approval · 2013-10-18FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin-D 12 Hour (loratadine and pseudoephedrine sulfate) from Bayer HealthCare LLC.
-
FDA approval · 2013-10-11FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
FDA approves a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) submitted by Chattem, Inc.
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: Comparison of Desloratadine Associated With Prednisolone (Tablet)Versus Dexchlorpheniramine Associated With Betamethasone (Tablet) for Adult Persistent Allergic Rhinitis Treatment [Phase 3]
Phase 3 clinical trial comparing desloratadine with prednisolone against dexchlorpheniramine with betamethasone for adult persistent allergi…
-
FDA approval · 2013-09-17FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Marlex Pharmaceuticals Inc)
FDA approved levocetirizine dihydrochloride under an original application for a generic antihistamine indicated for relief of symptoms of al…
-
FDA label_change · 2013-09-10FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental labeling application for Claritin Chewable Grape and Bubblegum (loratadine) from Bayer HealthCare LLC, updating …